Development Level

Tbio 1 | 11,445
Tclin 1 | 613
Tdark 1 | 6,588

Collection

GPCR: IDG Consortium (Targets) 1 | 126

IMPC Phenotype

abnormal retina morphology 1 | 71
abnormal sleep behavior 1 | 70
decreased bone mineral density 1 | 126
decreased erythrocyte cell num... 1 | 62
decreased prepulse inhibition 1 | 82
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
hypoactivity 1 | 132
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased or absent threshold ... 1 | 101
thrombocytopenia 1 | 56

Disease

Carcinoma 3 | 11,493
Bipolar Disorder 2 | 666
Multiple Sclerosis 2 | 540
Obesity 2 | 678
Vascular disease 2 | 319
astrocytoma 2 | 1,146
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
osteosarcoma 2 | 7,950
ovarian cancer 2 | 8,520
psoriasis 2 | 6,694
Abdominal pain, episodic 1 | 9
Absence of pubertal development 1 | 17
Absence of secondary sex characteristics 1 | 22
Acanthosis Nigricans 1 | 27
Acne 1 | 52
Acne vulgaris 1 | 14
Acquired metabolic disease 1 | 336
Adenocarcinoma 1 | 122
Adenocarcinoma of lung 1 | 142
Advanced Prostatic Carcinoma 1 | 5
Animal Mammary Neoplasms 1 | 136
Atrophic vulva 1 | 6
Bone Diseases, Metabolic 1 | 14
Breast Neoplasms 1 | 445
Breast disease 1 | 7
Breast fibroadenoma 1 | 8
Carcinoma of female breast 1 | 20
Carcinoma, Non-Small-Cell Lung 1 | 107
Carcinosarcoma 1 | 7
Cell Transformation, Neoplastic 1 | 97
Chemotherapy-induced nausea and vomiting 1 | 16
Colorectal cancer 1 | 25
Congenital hypoplasia of breast 1 | 25
Coronary Arteriosclerosis 1 | 6
Delayed epiphyseal ossification 1 | 10
Delayed maturation of end part of long bone 1 | 10
Diabetes Mellitus, Experimental 1 | 108
Disease Models, Animal 1 | 155
Dyspareunia 1 | 12
ESTROGEN RESISTANCE 1 | 2
Elevated gonadotropins 1 | 15
Elevated tissue non-specific alkaline phosphatase 1 | 1
Endometrial Neoplasms 1 | 55
Enlarged polycystic ovaries 1 | 10
Familial cancer of breast 1 | 12
Female Urogenital Diseases 1 | 18
Female hypogonadism syndrome 1 | 25
Female infertility 1 | 30
Feminization 1 | 1
Fetal overgrowth 1 | 16
Fibroid Tumor 1 | 6
Generalized osteopenia 1 | 99
Generalized overgrowth 1 | 16
Glomerulonephritis 1 | 46
Hyperinsulinism 1 | 133
Impaired glucose tolerance 1 | 28
Infantile uterus 1 | 23
Infertility, Female 1 | 28
Leiomyoma 1 | 32
Leiomyosarcoma 1 | 24
Lobular neoplasia 1 | 15
Lymphangioleiomyomatosis 1 | 16
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1 1 | 3
Mammary Neoplasms 1 | 425
Mammary Neoplasms, Animal 1 | 136
Mammary Neoplasms, Experimental 1 | 154
Marijuana Abuse 1 | 31
Marked delay in bone age 1 | 1
Menorrhagia 1 | 25
Mesothelioma 1 | 38
Metabolic Bone Disorder 1 | 11
Metastatic Breast Cancer Progression Post-Antiestrogen Therapy 1 | 4
Metastatic Breast Carcinoma 1 | 21
Metastatic Prostate Carcinoma 1 | 18
Migraine Disorders 1 | 76
Muscular atrophy 1 | 71
Musculoskeletal Pain 1 | 3
Myocardial Infarction 1 | 151
Neoplasm Metastasis 1 | 168
Neoplasm Recurrence, Local 1 | 37
Neoplastic Cell Transformation 1 | 89
Oligospermia 1 | 36
Osteopenia 1 | 99
Osteoporosis 1 | 363
Overgrowth 1 | 16
Plaque build-up in arteries supplying blood to heart 1 | 6
Premature ovarian failure 1 | 65
Premenstrual dysphoric disorder 1 | 8
Prevention of Post-Operative Nausea and Vomiting 1 | 14
Primary physiologic amenorrhea 1 | 55
Prostatic Intraepithelial Neoplasia 1 | 11
Prostatic Intraepithelial Neoplasias 1 | 11
Psychoses, Substance-Induced 1 | 17
Retinoblastoma 1 | 19
Shared Paranoid Disorder 1 | 5
Urinary Bladder Neoplasms 1 | 114
Uterine fibroid 1 | 28
cystic fibrosis and chronic rhinosinusitis 1 | 214
intermittent abdominal pain 1 | 9
non-small cell lung carcinoma 1 | 317

Tissue

Endocrine System 3 | 18,159
Male tissues 3 | 17,142
Nervous System 3 | 16,725
Blood and immune system 2 | 16,909
Cardiovascular System 2 | 15,192
Digestive Tract 2 | 17,369
Female tissues 2 | 17,400
Liver and Pancreas 2 | 16,750
Respiratory system 2 | 16,393
Skin and soft tissues 2 | 17,230
Urinary Tract 2 | 16,678

Target Family

GPCR 1 | 408
Nuclear Receptor 1 | 48
Transcription Factor 1 | 1,400

GO Process

antral ovarian follicle growth 3 | 3
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Forkhead box protein O3 FOXO3 Tbio Transcription Factor -2.94477 863.9 864
Probable G-protein coupled receptor 149 GPR149 Tdark GPCR -0.54429 3.90 147
Estrogen receptor ESR1 Tclin Nuclear Receptor -4.00480 8421.6 2610